Hybrid Therapy

Hybrid Therapy is a therapeutic regimen for Helicobacter pylori eradication that belongs to the class of multidrug antibiotic therapies and is distinguished by its sequential combination of a proton pump inhibitor and amoxicillin followed by the addition of clarithromycin and a nitroimidazole, thereby integrating features of both sequential and concomitant treatment strategies.

84

Publications

2.8K

Citations

484

Authors

225

Institutions

Publications per year

2017–2026

35

Variants

Hybrid H. Pylori Eradication Therapy

Authors

484

  1. DW
    Deng‐Chyang Wu

    Kaohsiung Medical University, Taiwan

    10 publications · 474 citations

    11

    h-index

  2. PH
    Ping‐I Hsu

    Kaohsiung Veterans General Hospital, Taiwan

    9 publications · 430 citations

    10

    h-index

  3. FT
    Feng‐Woei Tsay

    Kaohsiung Veterans General Hospital, Taiwan

    7 publications · 229 citations

    8

    h-index

  4. SK
    Sung‐Shuo Kao

    Kaohsiung Veterans General Hospital, Taiwan

    6 publications · 203 citations

    6

    h-index

  5. NP
    Nan‐Jing Peng

    Kaohsiung Veterans General Hospital, Taiwan

    5 publications · 167 citations

    5

    h-index

1–5 of 484

Venues

  1. Helicobacter

    7 publications · 400 citations

    7

    h-index

  2. Journal of Gastroenterology and Hepatology

    JGH · 4 publications · 156 citations

    4

    h-index

  3. 3

    h-index

  4. World Journal of Gastroenterology

    WJG · 3 publications · 58 citations

    3

    h-index

  5. Gastroenterology Research and Practice

    2 publications · 141 citations

    2

    h-index

1–5